Carcinoembryonic antigen (CEA) levels may serve as biomarker during follow-up, but cannot be used as reliable screening or diagnostic tool because of a lack in sensitivity and specificity in the early detection of CRC [92,93,94,95]. Here, CEACAM5 is linked to colorectal carcinoma.